Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai,
No information about this author
Xinbo Qiao,
No information about this author
Yuanyuan Fang
No information about this author
et al.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Nov. 26, 2024
Epigenetics
governs
a
chromatin
state
regulatory
system
through
five
key
mechanisms:
DNA
modification,
histone
RNA
remodeling,
and
non-coding
regulation.
These
mechanisms
their
associated
enzymes
convey
genetic
information
independently
of
base
sequences,
playing
essential
roles
in
organismal
development
homeostasis.
Conversely,
disruptions
epigenetic
landscapes
critically
influence
the
pathogenesis
various
human
diseases.
This
understanding
has
laid
robust
theoretical
groundwork
for
developing
drugs
that
target
epigenetics-modifying
pathological
conditions.
Over
past
two
decades,
growing
array
small
molecule
targeting
such
as
methyltransferase,
deacetylase,
isocitrate
dehydrogenase,
enhancer
zeste
homolog
2,
have
been
thoroughly
investigated
implemented
therapeutic
options,
particularly
oncology.
Additionally,
numerous
epigenetics-targeted
are
undergoing
clinical
trials,
offering
promising
prospects
benefits.
review
delineates
epigenetics
physiological
contexts
underscores
pioneering
studies
on
discovery
implementation
drugs.
include
inhibitors,
agonists,
degraders,
multitarget
agents,
aiming
to
identify
practical
challenges
avenues
future
research.
Ultimately,
this
aims
deepen
epigenetics-oriented
strategies
further
application
settings.
Language: Английский
ST8SIA6-AS1, a novel lncRNA star in liver cancer
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Aug. 15, 2024
Liver
cancer
is
one
of
the
most
lethal
gastrointestinal
malignancies.
Emerging
evidence
has
underscored
pivotal
role
long
non-coding
RNAs
(lncRNAs)
in
tumorigenesis,
with
ST8SIA6-AS1
identified
as
a
novel
oncogenic
lncRNA
contributing
to
liver
progression.
consistently
upregulated
hepatic
tissues
and
strongly
associated
unfavorable
prognosis.
Moreover,
it
demonstrates
high
diagnostic
efficacy
detecting
HCC.
involved
various
cellular
processes
including
proliferation,
migration,
invasion,
primarily
through
its
function
competing
endogenous
RNA
(ceRNA),
thereby
facilitating
hepatocarcinogenesis
disease
advancement.
This
review
provides
detailed
examination
molecular
functions
regulatory
mechanisms
hepatocellular
carcinoma
(HCC)
highlights
potential
promising
biomarker
for
cancer,
aiming
propel
development
innovative
therapeutic
strategies
HCC
management.
Language: Английский
Lasso-Based Nomogram for Predicting Early Recurrence Following Radical Resection in Hepatocellular Carcinoma
Guoqun Zheng,
No information about this author
Minjie Zheng,
No information about this author
Peng Hu
No information about this author
et al.
Journal of Hepatocellular Carcinoma,
Journal Year:
2025,
Volume and Issue:
Volume 12, P. 539 - 552
Published: March 1, 2025
Background:
Hepatocellular
carcinoma
(HCC)
is
a
common
malignancy
with
high
recurrence
rate
following
curative
resection.
This
study
aimed
to
identify
factors
contributing
early
(within
2
years)
and
develop
Lasso-based
nomogram
for
individualized
risk
assessment.
Methods:
We
conducted
retrospective
analysis
of
206
hCC
patients
who
underwent
resection
at
Taizhou
Hospital,
Zhejiang
Province,
from
January
2019
August
2022.
Patients
were
randomly
divided
into
training
(n=144)
validation
(n=62)
cohorts.
Lasso
regression
was
used
potential
among
17
candidate
predictors.
A
Cox
proportional
hazards
model
constructed
based
on
variables
selected
by
Lasso.
Model
performance
assessed
using
receiver
operating
characteristic
(ROC)
curves,
calibration
plots,
decision
curve
(DCA).
Results:
Five
independent
predictors
HCC
identified:
age,
serum
alanine
aminotransferase
(ALT)
levels,
cirrhosis,
tumor
diameter,
microvascular
invasion
(MVI).
The
demonstrated
area
under
the
(AUC)
values
recurrence-free
survival
(RFS)
0.828
(95%
confidence
interval
[CI]:
0.753–
0.904)
1
year,
0.799
CI:
0.718–
0.880)
years,
0.742
0.642–
0.842)
5
years
in
cohort.
corresponding
AUCs
cohort
0.823
0.686–
0.960),
0.804
0.922),
0.857
0.722–
0.992)
1,
respectively.
Calibration
curves
DCA
confirmed
nomogram's
accuracy
clinical
utility.
Conclusion:
Lasso-Cox
effectively
predicts
within
two
post-hepatectomy,
providing
valuable
tool
personalized
postoperative
management
improve
patient
outcomes.
Keywords:
hepatocellular
carcinoma,
invasion,
recurrence,
nomogram,
Language: Английский
LincRNA-miR interactions in hepatocellular carcinoma: comprehensive review and in silico analysis: a step toward ncRNA precision
Naunyn-Schmiedeberg s Archives of Pharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 23, 2025
Abstract
The
most
prevalent
form
of
primary
liver
cancer
and
one
the
chief
drivers
cancer-related
mortality
globally
is
hepatocellular
carcinoma
(HCC).
Imminent
evidence
has
indicated
that
non-coding
RNAs
(ncRNAs)
play
an
integral
part
in
development
propagation
HCC.
RNA
stabilization,
transcription
regulation,
chromatin
genomic
architecture
remodeling,
enhancer-associated
activity,
other
varied
properties
set
long
intergenic
ncRNA
(lincRNA)
genes
apart
from
messenger
(mRNA)-encoding
genes.
Through
a
variety
processes,
lincRNAs
may
generally
be
used
to
fine-tune
nearby
with
exceptional
tissue
specificity,
underscoring
our
quickly
developing
knowledge
genome.
their
binding
divergent
cell
targets,
some
HCC-related
ncRNAs
have
been
demonstrated
exhibit
abnormal
expression,
contribute
malignant
growth,
evade
apoptosis,
invasive
potential.
Therefore,
better
comprehension
lincRNA
dysregulation
might
offer
novel
perspectives
on
pathophysiology
HCC
as
well
innovative
instruments
for
early
detection
management
In
present
review,
we
provide
overview
increasing
relevance
major
contributor
HCC,
emphasizing
influence
signaling
pathways
implicated
development,
progression,
response
treatment
tumors.
addition,
go
over
new
approaches
target
possible
therapeutic
uses
prognostic
diagnostic
biomarkers
Graphical
multifaceted
roles
(lincRNAs)
Language: Английский
Multi-omics Analysis Revealed the Diagnostic and Therapeutic Value of Immunogenic Cell Death-derived SCN5A in Hepatocellular Carcinoma
Zicheng Liang,
No information about this author
Wei Tan,
No information about this author
Xiangdong Fang
No information about this author
et al.
Molecular Biotechnology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Language: Английский
Radiosensitization Strategies for Hepatocellular Carcinoma: Mechanisms, Therapeutic Advances, and Clinical Perspectives
Critical Reviews in Oncology/Hematology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 104773 - 104773
Published: May 1, 2025
Language: Английский
Regulatory effect of N6-methyladenosine on tumor angiogenesis
Yuyan,
No information about this author
Enwu Yuan
No information about this author
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 4, 2024
Previous
studies
have
demonstrated
that
genetic
alterations
governing
epigenetic
processes
frequently
drive
tumor
development
and
modifications
in
RNA
may
contribute
to
these
alterations.
In
the
1970s,
researchers
discovered
N6-methyladenosine
(m
Language: Английский
Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma
Federica Tonon,
No information about this author
Chiara Grassi,
No information about this author
Domenico Tierno
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12235 - 12235
Published: Nov. 14, 2024
The
increasing
incidence
of
hepatocellular
carcinoma
(HCC),
together
with
the
poor
effectiveness
available
treatments,
make
early
diagnosis
and
effective
screening
utmost
relevance.
Liquid
biopsy
represents
a
potential
novel
approach
to
HCC
detection
monitoring.
identification
blood
markers
has
many
desirable
features,
including
absence
any
significant
risk
for
patients,
possibility
being
used
as
tool,
ability
perform
multiple
tests,
thus
allowing
real-time
monitoring
evolution.
Unfortunately,
have
several
limitations,
mostly
related
specificity
sensitivity.
In
this
context,
employing
non-coding
RNAs
(ncRNAs)
may
represent
an
interesting
diagnostic
approach.
ncRNAs,
which
include,
among
others,
micro
interfering
(miRNAs),
long
(lncRNAs),
circular
(circRNAs),
regulate
human
gene
expression
via
interactions
their
target
mRNA.
Notably,
can
be
altered
in
HCC,
reflecting
disease
status.
review,
we
discuss
some
notable
works
that
describe
use
miRNAs,
lncRNAs,
circRNAs
biomarkers.
Despite
open
aspects
ncRNA
use,
presented
strongly
support
these
molecules
diagnostic/prognostic
HCC.
Language: Английский
miR-328-3p suppresses hepatocellular carcinoma progression by regulating HMOX1 expression
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 2, 2024
Most
oncogenic
genes
contribute
to
cancer
progression,
but
their
role
and
regulatory
mechanisms
are
not
yet
fully
understood
in
hepatocellular
carcinoma
(HCC).
This
study
aimed
explore
the
of
miR-328-3p
relationship
between
HMOX1
HCC.
We
utilized
Cox
LASSO
regression
identify
a
panel
associated
with
(HCC)
progression
within
TCGA-LIHC
cohort
GSE104580
dataset.
The
expression
levels
hub
gene,
HMOX1,
were
assessed
HCC
cell
lines
using
qPCR.
functional
roles
evaluated
through
series
vitro
assays,
including
CCK-8
for
proliferation,
colony
formation,
wound
healing,
Transwell
assays
migration
invasion.
direct
interaction
was
explored
luciferase
reporter
assay,
Western
blot
(WB)
protein
analysis,
determine
impact
on
proliferation
migration.
Eight
candidate
(BIRC5,
TNSF4,
SPP1,
ADM,
RBP2,
IGF1,
LECT2)
screen
out.
gene
among
had
high
level
lines.
High
expressing
line
significantly
increased
capacities.
Moreover,
identified
as
target
miR-328-3p,
which
regulated
qPCR
WB
assays.
diminished
capacities
However,
concurrent
upregulation
resulted
enhanced
proliferative
migratory
abilities
these
cells.
Our
has
advanced
our
understanding
HCC,
demonstrating
inhibitory
effect
activity
HMOX1.
Hence,
results
revealed
function
novel
mechanistic
pathway
suggested
potential
therapeutic
targeting
intervention
strategies.
Language: Английский
Crispr-Cas9-based long non-coding RNA interference and activation identified that the aberrant expression of Myc-regulated ST8SIA6 antisense RNA 1 promotes tumorigenesis and metastasis in hepatocellular carcinoma
Liu Xue-qian,
No information about this author
Dong Jiang,
No information about this author
Yang Liu
No information about this author
et al.
CytoJournal,
Journal Year:
2024,
Volume and Issue:
21, P. 53 - 53
Published: Nov. 25, 2024
Long
non-coding
RNAs
(lncRNAs)
participate
in
the
formation,
progression,
and
metastasis
of
cancer.
This
study
aimed
to
explore
roles
lncRNA
ST8SIA6
antisense
RNA
1
(ST8SIA6-AS1)
tumorigenesis
elucidate
underlying
molecular
mechanism
its
upregulation
hepatocellular
carcinoma
(HCC).
Language: Английский